UK Platform for Nucleic Acid Therapies (UPNAT) Inaugural Symposium

Book Now

The Medical Research Council (MRC) and National Institute for Health and Care Research (NIHR) have committed ca. £14m to establish a UK Rare Diseases Research Platform, comprising 11 "nodes" based in universities across the UK. Each node is working on a research project that is either focused on one disease area or across multiple rare diseases, and whilst the nodes are based at universities, we are also working with charities, industry and other universities to ensure that we are reaching the right people for our research.

We are the UPNAT Node ("Establishing a UK Platform of Nucleic Acid Therapy for Rare Disease").

The agenda will include sessions on:

Real-world experience from patients & clinicians

• Piotr Kosla (parent, PACS2 Research Foundation, and Simons Searchlight Community Advisory Committee member)

• Francesco Muntoni (Chair of Paediatric Neurology, UCL)

Target selection

• Stephan Sanders (Professor of Neurogenetics, Oxford)

• Ana Lisa Taylor Tavares (Clinical Lead for rare disease research, Genomics England)
• Willeke van Roon-Mom (Professor of Human Genetics, Leiden University)

Clinical trials and regulatory path

• Sarah Tabrizi (Professor of Clinical Neurology, UCL)
• David Fischer (Chief Technology Officer - Discovery, Charles River Labs)

• Daniel O’Connor (Director of Regulatory and Early Access Policy, Association of the British Pharmaceutical Industry)

+Panel discussions

• chaired by Jenny Taylor (Professor of Translational Genomics, University of Oxford)
• chaired by Paul Gissen (Clinical Professor of Paediatric Metabolic Medicine, UCL Great Ormond Street Institute of Child Health)